Clinical Trials for Diamond Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Diamond Therapeutics

Clinical Trials (3)

NCT06969170
Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
PHASE2Recruiting
50 participants
Started: May 6, 2025 · Completed: Aug 30, 2026
1 condition3 sponsors1 location
NCT05227742
Exploratory Study of Low Dose Psilocybin
EARLY_PHASE1Recruiting
60 participants
Started: Aug 15, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05256290
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
PHASE1/PHASE2Active, not recruiting
200 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2026
10 conditions1 sponsor41 locations